Anti-angiogenetic metronomic chemotherapy in an adult patient with recurrent medulloblastoma with spinal metastases: a case report

  • J. Buchroithner
  • K. Nußbaumer
  • R. Pichler
  • S. Weis
Case report
First Online:
Received:
Accepted:

Summary

We present the case of a 33-year-old man, who was diagnosed with a cerebellar medulloblastoma in October 2000. Surgery with complete resection followed by craniospinal fractionated radiation therapy. The recurrences were treated according to HIT 2000 and the 3rd recurrence was treated by a metronomic anti-angiogenetic therapy. Technical advances in diagnostics, surgery and radiotherapy increased prognoses for patients with brain tumours. Case reports in the literature show encouraging results with second and third line chemotherapy, anti-angiogenic drugs and targeted therapy for example with somatostatin analogues. These therapies may further improve prognosis and enable "living with cancer" for years even for patients with fatal prognosis like disseminated spinal metastases of adult medulloblastoma.

Keywords

PNET Adult medulloblastoma HIT 2000 Metronomic anti-angiogenetic therapy 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas B. Cancer inidence in fife continents, Vol. III. Int Age Res Cancer, Lyon, 2002. IARC sient. Publ. No. 155Google Scholar
  2. Lai R. Survival of patients with adult medulloblastoma: a population-based study. Cancer, 112(7): 1568–1574, 2008CrossRefPubMedGoogle Scholar
  3. Herrlinger U, Steinbrecher A, Rieger J, Hau P, Kortmann RD, Meyermann R, Schabet M, Bamberg M, Dichgans J, Bogdahn U, Weller M. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol, 252(3): 291–299, 2005CrossRefPubMedGoogle Scholar
  4. Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T. Survival and prognostic factors in a series of adults with medulloblastomas. J Neurosurg, 111(3): 478–487, 2009CrossRefPubMedGoogle Scholar
  5. Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology, 93: 1351–1359, 1969.PubMedGoogle Scholar
  6. Brandes AA, Franceschi E, Tosoni A, Reni M, Gatta G, Vecht C, Kortmann RD. Adult neuroectodermal tumors of posteria fossa (medulloblastoma) and of supratentorial sites (stPNET). Crit Rev Oncol Hematol, 71(2): 165–179, 2009CrossRefPubMedGoogle Scholar
  7. Brandes AA, Franceschi E, Tosoni A, Blatt V, Ermani M. Long-term results of a prospective study on the treatment of medulloblastome in adults. Cancer, 110(9): 2035–2041, 2007CrossRefPubMedGoogle Scholar
  8. Brandes AA, Ermani M, Amista P, Basso U, Vastola F, Gardiman M, Iuzzolino P, Turazzi S, Rotilio A, Volpin L, Mazza C, Sainati L, Ammannati F, Berti F. The treatment of adults with medulloblastoma: a prospective study. Int J Radiat Oncol Biol Phys, 57(3): 755–761, 2003PubMedGoogle Scholar
  9. Kieran MW, Turner CD, Rubin JB, Chi SN, Zimmerman MA, Chordas C, Klement G, Laforme A, Gordon A, Thomas A, Neuberg D, Browder T, Folkman J. A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer. J Pediatr Hematol Oncol, 27(11): 573–581, 2005CrossRefPubMedGoogle Scholar
  10. Poelen J, Bernsen HJJA, Prick MJJ. Metastatic medulloblastoma in an adult: treatment with temozolomide. Acta Neurol Belg, 107: 51–54, 2007PubMedGoogle Scholar
  11. Durando X, Thivat E, Gilliot O, Irthum B, Verelle P, Vincent C, Bay JO. Temozolomide treatment of an adult with a relapsing medulloblastoma. Cancer Invest, 25(6): 470–475, 2007CrossRefPubMedGoogle Scholar
  12. Privitera G, Aquaviva G, Ettorre GC, Spatola C. Antiangiogenetic therapy in the treatment of recurrent medulloblastoma in the adult. J Oncol, 2009:247873. [Epub. 2009 Dec. 30]Google Scholar
  13. Glas M, Hennemann B, Hirschmann B, Marienhagen J, Schmidt-Wolf I, Herrlinger U, Boghdan U, Hau P. Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma. Acta Oncologica, 47(3): 479–480, 2008CrossRefPubMedGoogle Scholar
  14. Stefanovic I, Stjanovic N, Stojanov D, Dimov D. Octreotide in the therapy of recurrent medulloblastomas. Arch Oncol, 14(1–2): 26–29, 2006CrossRefGoogle Scholar

Copyright information

© Springer 2010

Authors and Affiliations

  • J. Buchroithner
    • 1
  • K. Nußbaumer
    • 2
  • R. Pichler
    • 3
  • S. Weis
    • 4
  1. 1.Department of NeurosurgeryLandesnervenklinik Wagner-JaureggLinzAustria
  2. 2.Department of NeuroradiologyLandesnervenklink Wagner-JaureggLinzAustria
  3. 3.Department of Nuclear MedicineLandesnervenklinik Wagner-JaureggLinzAustria
  4. 4.Department of NeuropathologyLandesnervenklinik Wagner-JaureggLinzAustria

Personalised recommendations